(VIANEWS) - AAON (AAON), CBAK Energy Technology (CBAT), Zoetis (ZTS) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. AAON (AAON)
65.3% sales growth and 12.76% return on equity
AAON, Inc., along with its affiliates, is involved in manufacturing, marketing, engineering, and selling heating and air conditioning equipment throughout the United States. The company has three divisions: AAON Oklahoma and AAON Coil Products. It offers rooftop units, data center cooling solutions, cleanroom systems, chillers, packaged outdoor mechanical rooms, air handling units, makeup air units, energy recovery units, condensing units, geothermal/water-source heat pumps, coils, and controls. It sells products in retail, commercial, industrial, education, lodging, hospital, data center, pharmaceutical and other industries. The company sells products via a network independent distributor organizations as well as an internal sales force. It was founded in Oklahoma in 1987.
Earnings Per Share
As for profitability, AAON has a trailing twelve months EPS of $1.03.
PE Ratio
AAON has a trailing twelve months price to earnings ratio of 52.31. Meaning, the purchaser of the share is investing $52.31 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.76%.2. CBAK Energy Technology (CBAT)
20.5% sales growth and 26.01% return on equity
Through its subsidiaries, CBAK Energy Technology, Inc. develops, produces, and markets lithium batteries throughout Mainland China, America, Europe, Taiwan, Israel, Taiwan, and the rest of the world. The company's products can be used for a variety of purposes, including electric cars such as hybrid cars and electric buses as well as light electric vehicles which include electric bikes, motors and sight-seeing vehicles. It also makes energy storage and uninterruptible electricity supply. The business was previously known as China BAK Battery, Inc., but it changed its name to CBAK Energy Technology, Inc. on January 2017. CBAK Energy Technology, Inc. is located in Dalian, China.
Earnings Per Share
As for profitability, CBAK Energy Technology has a trailing twelve months EPS of $0.33.
PE Ratio
CBAK Energy Technology has a trailing twelve months price to earnings ratio of 3.48. Meaning, the purchaser of the share is investing $3.48 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 26.01%.Revenue Growth
Year-on-year quarterly revenue growth grew by 856.8%, now sitting on 173.91M for the twelve trailing months.
Earnings Before Interest, Taxes, Depreciation, and Amortization
CBAK Energy Technology's EBITDA is 52.62.
Moving Average
CBAK Energy Technology's value is way under its 50-day moving average of $1.31 and below its 200-day moving average of $1.24.3. Zoetis (ZTS)
9.9% sales growth and 47.31% return on equity
Zoetis Inc. develops, produces, markets, and sells diagnostic and animal medicine products, vaccines and other health products both in the United States as well as internationally. The company sells its products across a variety of species. This includes livestock such as sheep, cattle, chicken, fish and poultry; companion animals including dogs, cats and horses. It also sells vaccines. These are biological preparations designed to prevent disease in the respiratory, digestive, and reproductive tracts. Other pharmaceutical products include antiemetic and reproductive products, pain and sedation products, dermatology products to treat allergic conditions, and medications for livestock. The company also offers portable urine and blood analysis, which includes instruments and reagents for point-of care diagnostics. It can also provide reference kits, laboratory kits, blood glucose monitors, blood glucose monitoring, blood sugar monitors, and rapid immunoassay testing. The company markets its products directly to livestock producers and veterinarians. It also sells its products through third-party distributors. It was established in Parsippany in New Jersey in 1952.
Earnings Per Share
As for profitability, Zoetis has a trailing twelve months EPS of $3.42.
PE Ratio
Zoetis has a trailing twelve months price to earnings ratio of 42.7. Meaning, the purchaser of the share is investing $42.7 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 47.31%.Growth Estimates Quarters
The company's growth estimates for the current quarter and the next is 2.5% and 4.8%, respectively.4. Genuine Parts Company (GPC)
9.8% sales growth and 31.98% return on equity
Genuine Parts Company supplies automotive parts as well as industrial parts. The company operates in two segments: Automotive Parts Group, and Industrial Parts Group. It distributes replacement parts for vehicles such as hybrids and electrics. The company also sells replacement parts for industrial applications and supplies such as bearings and mechanical power transmission products. It also supplies hoses and hydraulic components. The company also offers various repairs, including hydraulic panel repair and assembly, fluid power pump repair and maintenance, hydraulic drive shaft assembly and repair and hose and gasket manufacturing and assembly. The company operates across the United States and Canada. It was founded in 1928 in Atlanta, Georgia.
Earnings Per Share
As for profitability, Genuine Parts Company has a trailing twelve months EPS of $0.37.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 31.98%.Growth Estimates Quarters
The company's growth estimates for the ongoing quarter and the next is 9% and 3.9%, respectively.Revenue Growth
Year-on-year quarterly revenue growth grew by 17.1%, now sitting on 20.52B for the twelve trailing months.
Sales Growth
Genuine Parts Company's sales growth is 11.7% for the current quarter and 9.8% for the next.